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Abstract
Background: Scabies causes considerable morbidity in disadvantaged populations. The International Alliance for
the Control of Scabies (IACS) published consensus criteria in 2020 to standardize scabies diagnosis. However, these
criteria are complex, and a WHO informal consultation proposed simplified criteria for mapping, to identify regions
of high prevalence as targets for mass drug administration. We aimed to investigate the accuracy of simplified
criteria in determining scabies prevalence, compared to the 2020 IACS criteria.
Methods: We obtained data relating to demographics, relevant history and skin lesions from all-age prevalence
surveys from Fiji (n = 3365) and Solomon Islands (n = 5239), as well as school-aged children in Timor-Leste (n =
1043). We calculated prevalence using the 2020 IACS criteria and simplified criteria and compared these disease
estimates.
Results: There was no significant difference in the pooled prevalence using the two methods (2020 IACS criteria:
16.6%; simplified criteria: 15.6%; difference = 0.9, [95% CI -0.1, 2.0]). In Timor-Leste, the prevalence using simplified
criteria was lower (26.5% vs 33.8%). Simplified criteria had a sensitivity of 82.3% (95% CI 80.2, 84.2) and specificity of
97.6% (95% CI 97.2, 97.9) compared to the 2020 IACS criteria.
Conclusions: The scabies prevalence estimation using simplified criteria was similar to using the 2020 IACS criteria
in high prevalence, tropical countries. The prevalence estimation was lower in the school-based survey in Timor-
Leste. Mapping using simplified criteria may be a feasible and effective public health tool to identify priority regions
for scabies control. Further work assessing use of simplified criteria for mapping in a field setting should be
conducted.
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Background
Scabies is a skin condition caused by the microscopic
ectoparasite Sarcoptes scabiei var. hominis. It affects an
estimated 150–200 million people worldwide [1], with
an estimated annual incidence globally in 2019 of 565
(499–634) million cases and disease burden of 4.84 mil-
lion disability-adjusted life-years [2]. Infestation with the
scabies mite increases the risk of secondary bacterial
complications such as impetigo, complicated skin and
invasive infections, and immune-mediated conditions
such as post-streptococcal glomerulonephritis and acute
rheumatic fever [3]. Scabies is classified as a Neglected
Tropical Disease (NTD) by the World Health
Organization (WHO) warranting large-scale action for
public health control [4–6]. Ivermectin-based mass drug
administration (MDA) is effective for disease control in
communities with high scabies prevalence (≥10%) [7–9].
Thus, a priority in the strategy for scabies control is es-
tablishing standardised diagnostic and survey methods
to identify target areas for MDA.
While scabies is definitively diagnosed with direct
microscopic visualisation of the mite or its products
from skin scrapings, this test is not suitable in field set-
tings due to cost, requirements for training and access
to equipment, and low sensitivity [10, 11]. To standard-
ise diagnosis, the International Alliance for the Control
of Scabies (IACS) developed consensus criteria (2020
IACS criteria, Table S1) encompassing varying levels of
diagnostic complexity for use in a variety of research,
clinical or public health settings [12, 13]. For public
health settings where direct visualisation techniques are
not possible, a diagnosis of ‘Clinical Scabies’ or ‘Sus-
pected Scabies’ using the 2020 IACS criteria requires the
examining field worker to take a brief history of itch and
contacts and do a skin examination. Initial validation of
clinical assessment for non-expert examiners using the
2020 IACS criteria has shown moderate sensitivity and
good specificity [14, 15].
However, assessment of contact history can be time
consuming, and may not be reliable [15]. Simplified cri-
teria defining ‘typical lesions in a typical distribution,
with or without itch’ as scabies cases, were proposed by
the 2019 WHO Informal Consultation on a Framework
for Scabies Control as an alternative, based on the as-
sumption that these criteria would be more efficient and
feasible for rapid mapping purposes as they utilised an
abbreviated examination and omitted assessment of con-
tact history [16]. However, the accuracy of prevalence
estimates using these simplified criteria is not known,
and an evaluation was identified as an operational re-
search priority by the WHO Informal Consultation [16,
17]. A high scabies prevalence has previously been iden-
tified in several Pacific and southeast Asian countries,
including Fiji, Solomon Islands and Timor-Leste [5]. We
aimed to evaluate the accuracy of prevalence estimations
obtained by simplified criteria compared to the 2020
IACS criteria in surveys completed in these countries.
Further, we aimed to investigate whether these estimates
differ by country, sex, or age. Lastly, we aimed to explore




Fiji and Solomon Islands are Pacific Island countries
with estimated populations in 2019 of 890,000 and
670,000 respectively [18], Timor-Leste is a southeast
Asian country composed of the eastern half of the island
of Timor, Atauro Island, Jaco Island and the enclave of
Ambeno, and had an estimated population of 1.3 million
in 2019 [18]. A national survey of scabies and impetigo
in Fiji in 2017 estimated scabies prevalence of 18.5%
[19]. Although no nationwide data are available for Solo-
mon Islands and Timor-Leste, previous regional surveys
between 2014 and 2016 estimate prevalence of 18.2–
19.2%, and 17.0%, respectively [8, 20, 21].
Study population and procedures
In this study of diagnostic accuracy [22], we utilised data
collected during three prevalence surveys for scabies
from Fiji, Solomon Islands and Timor-Leste [23–25].
De-identified data were collated from the three countries
into a single dataset, including details on age, sex, coun-
try and findings of skin examination and history.
The three surveys were designed and conducted using
identical methods for data collection and diagnosis. Sur-
vey procedures and sample size calculations are reported
in detail elsewhere [23–26]. In brief, the studies in Solo-
mon Islands and Fiji were community prevalence sur-
veys involving participants of all ages. In Solomon
Islands, residents from 20 villages in the Western Prov-
ince were surveyed between May and July 2019, result-
ing in a total of 5239 participants. In Fiji, 3365
participants from 16 communities in the Northern Div-
ision were recruited in May 2019 [24]. In Timor-Leste, a
school-based survey was conducted between April and
May 2019, and enrolled a total of 1043 school children
and their siblings aged less than 19 years of age from
schools across three different municipalities [23].
A standardised training program was used to train
nurses and doctors across the three sites, based on an
established program [15]. In brief, local healthcare
workers completed a one-week training program incorp-
orating interactive tutorials on the features of scabies,
based on the clinical categories of the 2020 IACS criteria
which are the recommended standards for prevalence
surveys [12]. This was followed by a written assessment
of clinical photographs, requiring a minimum pass rate
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of 80%, and supervised practical sessions [23]. Demo-
graphic data relating to sex, age, locality and ethnicity
were recorded. Positive contact history was elicited by
asking participants whether they had household or other
close contacts with itch, or with a typical scabies rash.
Participants were shown photos of typical scabies rashes
for reference. The skin of the head and neck, and upper
and lower limbs was then inspected. The groin, buttocks,
axillae and torso were not routinely examined. Examin-
ation of the trunk was included for children aged less
than two years, consistent with the typical distribution
of scabies in this group [12]. Examiners recorded the
number of typical or atypical scabies lesions present and
their location. Dermoscopy, skin scrapings and micros-
copy were not used as they are not usually available in
clinical practice in these settings.
Case definitions
The reference standard for diagnosis was the clinical cat-
egories of the 2020 IACS criteria (Table 1) [12]. Cases
were classified as positive for scabies if they fulfilled ei-
ther the criteria for ‘Clinical Scabies’ (subcategory B3),
or ‘Suspected Scabies’ (subcategories C1 or C2), based
on lesion appearance, lesion distribution, history of itch
and contact history. Categories of the 2020 IACS criteria
that require examination of the groin or specialised
equipment and training, were not included (Table S1).
Diagnosis using the simplified criteria was considered
the index test. Simplified criteria were taken from the
WHO Informal Consultation recommendations as ‘typ-
ical lesions and distribution of scabies on exposed skin,
with or without itch’ [16]. The simplified criteria differs
from the 2020 IACS criteria in that contact history and
atypical lesions are not included (Table 2). Training re-
quirements for examiners for simplified criteria may
thus be reduced.
Four alternative index tests were also investigated
(Table 1). Two tests were chosen in an effort to capture
cases which were classified as ‘Suspected Scabies’ by the
2020 IACS criteria, whilst remaining practical to imple-
ment in the field setting. These test criteria included
‘Atypical lesions in a typical distribution of scabies in
frequently exposed skin areas, with itch (ASC1)’, and
‘Atypical lesions in a typical distribution of scabies in
frequently exposed skin areas, with or without itch
(ASC2)’. Two further alternatives, which would not re-
quire any skin inspection were also explored (ASC3:
‘Presence of itch’ and ASC4: ‘Presence of itch and posi-
tive contact history’). Based on each study participant’s
recorded data, they were classified as either having or
not having scabies, against each of the 2020 IACS cri-
teria, simplified criteria, and the four alternative simpli-
fied criteria.
Statistical analysis
Participants were excluded from analysis if data were
missing (Fig. S1). We used descriptive statistics to calcu-
late the prevalence of scabies overall, as well as for each
country, sex and age group. We categorised age groups
to enable comparison of children aged less than two
years and children aged two to four years, as these can
have a different clinical pattern of scabies [12]. Older
ages were divided to give approximately even numbers
of participants in each group. The difference in preva-
lence estimates was calculated, with 95% confidence in-
tervals. We compared sex and age groups using relative
risk [27]. Diagnostic accuracy of the simplified criteria
strategy was analysed by calculating sensitivity and speci-
ficity compared with the 2020 IACS criteria, with 95%
confidence intervals. Cohen’s kappa (κ) statistic was used
to evaluate the inter-rater agreement for the classifica-
tion of scabies using the different criteria. In further sec-
ondary analysis, we evaluated the four alternative
simplified criteria by calculating prevalence estimates
and sensitivity and specificity for each set of criteria. We
used Stata/IC 16.1 (Statacorp LP, College Station Tx,
USA) for all analysis.
Results
A total of 9632 participants were recruited from the
three studies. Following exclusion of 120 participants
Table 1 Scabies diagnostic criteria used in study
1. Reference Standard: 2020 IACS criteria (clinical categories used
in study)
Subcategory B3: Typical lesions in a typical distribution and two
history features
Subcategory C1: Typical lesions in a typical distribution and one
history features
Subcategory C2: Atypical lesions or atypical distribution and two
history features
*History features: itch; positive contact history
2. Index Tests
A. Simplified criteria
Typical lesions in a typical distribution, with or without itch
B. Alternative simplified criteria 1 (ASC1)
At least one of:
i. Typical lesions in a typical distribution, with or without itch
ii. Atypical lesions in a typical distribution, with itch
C. Alternative simplified criteria 2 (ASC2)
At least one of:
i. Typical lesions in a typical distribution, with or without itch
ii. Atypical lesions in a typical distribution, with or without itch
D. Alternative simplified criteria 3 (ASC3)
Itch
E. Alternative simplified criteria 4 (ASC4)
Itch and positive contact history
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with incomplete data, a total of 9526 participants were
included in the analysis (Fig. S1). The majority of partici-
pants (54.8%) were from the Solomon Islands, with
fewer from Fiji (35.2%) and Timor-Leste (10.0%). There
were slightly fewer males included (47.6%). The median
age of participants was 15 years old (interquartile range
8–38 years old, range 0–98 years old) and the largest
proportion of participants ranged from 5 to 14 years old
(35.1%, Table 3). There was a higher proportion of par-
ticipants aged less than 15 years old in the Solomon
Islands survey compared to the 2009 national census
(48.0% vs 41.0%) [28]. The age distribution of partici-
pants from Timor-Leste was different (median 10 years
old; interquartile range 8–11 years old) as that survey
only included children. There were no substantial differ-
ences in age or sex structure of the sample population in
Table 2 Comparison of simplified diagnostic criteria to 2020 IACS criteria
2020 IACS criteria Simplified criteria
History Features
Itch Included. At least one of Itch or
Contact History required
Included; not required




Body Regions Whole body, where feasible
Limited examination of exposed areas may be appropriate
in field surveys
Frequently exposed areas only
Lesion Appearance Atypical scabies lesions can be included if there is a typical
distribution and both history features are present
Typical scabies lesions required
Lesion Distribution Atypical distribution can be included where there are typical
scabies lesions and both history features are present
Typical scabies distribution required
Implementation Features
Specialised Equipment Direct visualisation equipment for confirmed scabies, where
feasible
No
Examiner Minimum Level Experienced healthcare worker (nurse or physician) Community health worker
Training Longer, more specialised training and accreditation







Accurate determination of prevalence (e.g., sentinel sites,
impact surveys)
Community survey/mapping
Defining areas where prevalence is likely to be ≥ 10%
and a mass drug administration strategy may be
recommended
Table 3 Demographics of participants
Solomon Islands Fiji Timor-Leste Total
Sex
Male 2473 (47.3%) 1625 (48.5%) 439 (46.2%) 4537 (47.6%)
Female 2751 (52.7%) 1726 (51.5%) 512 (53.8%) 4989 (52.4%)
Age (years)
0–1 263 (5.0%) 171 (5.1%) 4 (0.4%) 438 (4.6%)
2–4 541 (10.4%) 258 (7.7%) 19 (2.0%) 818 (8.6%)
5–9 900 (17.2%) 403 (12.0%) 438 (46.1%) 1741 (18.3%)
10–14 804 (15.4%) 310 (9.3%) 482 (50.7%) 1596 (16.8%)
15–29 990 (19.0%) 719 (21.5%) 8 (0.8%) 1717 (18.0%)
30–49 1051 (20.1%) 809 (24.1%) 0 1860 (19.5%)
≥ 50 675 (12.9%) 681 (20.3%) 0 1356 (14.2%)
Total 5224 (54.8%) 3351 (35.2%) 951 (10.0%) 9526 (100.0%)
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Fiji compared to the overall population reported in the
2017 census.
Prevalence by 2020 IACS criteria
Using the 2020 IACS criteria, 1577 individuals (16.6%,
[95% CI 15.8, 17.3], Table 4) were classified as cases
of scabies. This included 880 cases (55.8% of cases) of
‘Clinical Scabies’, and 697 cases (44.2% of cases) of
‘Suspected Scabies’ (C1: 418 cases, 26.5% of cases;
and C2: 279 cases, 17.7% of cases, Table 5). The
prevalence of ‘Suspected Scabies subcategory C2’ in
Timor-Leste was 8.9% (26.5% of cases), 2.7% in Solo-
mon Islands (18.2% of cases) and 1.5% in Fiji (10.9%
of cases, Table 5). Itch was present in 1470 cases
(93.2% of cases), and contact history in 1266 (80.3%
of cases, Table 5) [23].
The prevalence of scabies (either ‘Clinical Scabies’ or
‘Suspected Scabies’) was 33.8% in Timor-Leste, 15% in
Solomon Islands, and 14% in Fiji (Table 4). A higher
proportion of males (17.7%) were classified as having
scabies compared to females (15.5%, relative risk (RR)
1.1, [95% CI 1.0, 1.3]). Scabies was more commonly di-
agnosed in younger age groups, with a prevalence of
24.4% in children aged less than 15 years, compared to
those aged 15 years or older (prevalence 9.2%; RR 2.6,
[95% CI 2.4, 2.9]).
Prevalence by simplified criteria
The differences in the prevalence estimates obtained by
the 2020 IACS criteria and the simplified criteria were
not significant overall (16.6% vs 15.6%, difference 0.9,
[95% CI -0.1, 2.0], Table 4) or in Solomon Islands or Fiji.
In Timor-Leste, the 2020 IACS criteria prevalence was
higher than the simplified criteria prevalence (33.8% vs
26.5%, difference 7.3, [95% CI 3.1, 11.4], Table 4). There
was very strong agreement between the two prevalence
estimates overall (κ = 0.82, [95% CI 0.80, 0.83], Table 4).
In Timor-Leste the agreement was moderately strong
(κ = 0.75, [95% CI 0.73, 0.77]). There were no statistical
differences between the estimates using the two methods
by sex or age groups.
Sensitivity and specificity of simplified criteria
Overall, simplified criteria had a sensitivity of 82.3%
(95% CI 80.2, 84.2) and specificity of 97.6% (95% CI
97.2, 97.9, Table 6) compared to the 2020 IACS criteria.
There were 279 false negative cases (2.9% of all partici-
pants), all of whom had itch and a positive contact his-
tory but atypical features in either lesion appearance or
distribution (2020 IACS criteria subcategory C2), thus
failing to meet the simplified criteria definition. As con-
tact history is not included in the simplified criteria,
these cases were categorised as negative. The 192 false
Table 4 Comparison of prevalence estimates between 2020 IACS criteria and simplified criteria














Total (n = 9526) 1577 16.6 (15.8, 17.3) 1490 15.6 (14.9, 16.4) 0.9 (−0.1, 2.0) 0.82 (0.80–0.83)
Country
Solomon Islands (n = 5224) 786 15.0 (14.1, 16.0) 788 15.1 (14.1, 16.1) −0.0 (−1.4, 1.3) 0.79 (0.77–0.80)
Fiji (n = 3351) 470 14.0 (12.9, 15.2) 450 13.4 (12.3, 14.6) 0.6 (−1.15, 2.2) 0.90 (0.88–0.91)
Timor-Leste (n = 951) 321 33.8 (30.8, 36.8) 252 26.5 (23.8, 29.4) 7.3 (3.1, 11.4) 0.75 (0.73–0.77)
Sex
Male (n = 4537) 804 17.7 (16.6, 18.9) 772 17.0 (15.9, 18.1) 0.7 (−0.9, 2.3) 0.82 (0.81–0.84)
Female (n = 4989) 773 15.5 (14.5, 16.5) 718 14.4 (13.4, 15.4) 1.1 (−0.3, 2.5) 0.81 (0.80–0.83)
Age (years)
0–1 (n = 438) 124 28.3 (24.3, 32.7) 135 30.8 (26.7, 35.3) −2.5 (−8.6, 3.5) 0.84 (0.83–0.86)
2–4 (n = 818) 212 25.9 (23.0, 29.0) 220 26.9 (24.0, 30.0) −1.0 (−5.3, 3.3) 0.81 (0.80–0.83)
5–9 (n = 1741) 450 25.8 (23.8, 28.0) 440 25.3 (23.3, 27.4) 0.6 (−2.3, 3.5) 0.81 (0.79–0.82)
10–14 (n = 1596) 336 21.1 (19.1, 23.1) 319 20.0 (18.1, 22.0) 1.1 (−1.7, 3.9) 0.78 (0.77–0.80)
15–29 (n = 1717) 180 10.5 (9.1, 12.0) 163 9.5 (8.2, 11.0) 1.0 (−1.0, 3.0) 0.80 (0.79–0.82)
30–49 (n = 1860) 158 8.5 (7.3, 9.9) 123 6.6 (5.6, 7.8) 1.9 (0.2, 3.6) 0.83 (0.81–0.84)
≥ 50 (n = 1356) 117 8.6 (7.2, 10.2) 90 6.6 (5.4, 8.1) 2.0 (−0.0, 4.0) 0.82 (0.80–0.83)
CI = confidence interval
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positives (2.0% of all participants) had typical lesions in a
typical distribution but neither itch nor contact history
(at least one of which is required by the 2020 IACS
criteria).
Sensitivity and specificity did not vary between males
and females. The sensitivity was highest in children aged
less than two years (92.7%) and decreased with age
(73.5% in those ≥50 years). Specificity increased with age
(93.6% in children aged less than two years to 99.7% in
those aged ≥30 years, Table 6).
Alternative simplified criteria
The proportion of individuals classified as having scabies
estimated by alternative simplified criteria ASC1, ASC2
and ASC3 were significantly higher than estimates using
2020 IACS criteria (ASC1: 20.3%, difference = − 3.7%
[95% CI −4.8, − 2.6], ASC2: 23.8%, difference = − 7.2%
[95% CI −8.3, − 6.1], ASC3: 27.8%, difference = − 11.2%
[95% CI −12.4, − 10.0], Table S2). ASC4 produced the
most similar prevalence estimate overall of 16.7% (differ-
ence = − 0.1%, [95% CI −1.2, 0.9]) however greatly
overestimated scabies prevalence in those younger than
five years old (difference = 6.1%, [95% CI 2.7, 9.4]). Use
of the alternate criteria led to an increase in sensitivity
for ASC1 (99.7%, [95% CI 99.3, 99.9]), ASC2 (99.7%,
[95% CI 99.3, 99.9]) and ASC3 (93.2%, [95% CI 91.9,
94.4]), however all four alternative criteria had lower
specificity (Table S3).
Discussion
Our results suggest that the simplified criteria proposed
by the WHO Informal Consultation can be used to ac-
curately estimate the prevalence of scabies during rapid
mapping and surveys, with a similar prevalence estimate
when compared to assessment using the 2020 IACS cri-
teria. The simplified criteria had a sensitivity of 82% and
specificity of 98%. We believe this accuracy is acceptable
for the purposes of surveys, where public health deci-
sions are made based on community prevalence, rather
than treatment decisions based on individual diagnoses.
Rapid mapping aims to identify areas where the com-
munity prevalence of scabies is ≥10% (or ≥ 15% in
Table 5 Breakdown of scabies cases by 2020 IACS Criteria


























Timor-Leste 310 (96.6%) 279 (86.9%) 236 (73.5%) 321 (100.0%) 321 183
(55.8%)
53 (16.5%) 85 (26.5%)
Sex













0–1 110 (88.7%) 94 (75.8%) 115 (92.7%) 124 (100.0%) 124 71 (57.3%) 44 (35.5%) 9 (7.3%)
2–4 205 (96.7%) 164 (77.4%) 186 (87.7%) 212 (100.0%) 212 131
(61.8%)
55 (25.9%) 26 (12.3%)





10–14 307 (91.4%) 281 (83.6%) 271 (80.7%) 336 (100.0%) 336 187
(55.7%)
84 (25.0%) 65 (19.3%)
15–29 167 (92.8%) 134 (74.4%) 142 (78.9%) 179 (99.4%) 180 82 (45.6%) 59 (32.8%) 39 (21.7%)
30–49 146 (92.4%) 137 (86.7%) 121 (76.6%) 155 (98.1%) 158 85 (53.8%) 33 (20.9%) 40 (25.3%)
≥ 50 112 (95.7%) 87 (74.4%) 87 (74.4%) 116 (99.1%) 117 51 (43.6%) 35 (29.9%) 31 (26.5%)
Total 1470
(93.2%)
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school-aged children, if a school-survey method is used)
for implementation of MDA programs [16]. Based on
our data in these three countries where scabies preva-
lence was > 10%, use of simplified criteria as opposed to
2020 IACS criteria would not lead to a different recom-
mendation for where MDA should be implemented.
This study demonstrates that the simplified criteria may
be useful in regions with a high scabies prevalence. This
is an important finding as these are the regions where
the public health control of scabies using MDA is being
prioritised, but where there are currently very little or
no estimates of prevalence. However, it is possible that
in populations where scabies prevalence is close to the
recommended MDA starting threshold, choice of criteria
may impact public health decision making.
Accurate mapping strategies are important to iden-
tify and prioritise areas for scabies control and MDA,
but these methods need to be feasible at large scale.
Rapid mapping strategies, using simplified criteria,
have been successfully used for the control of other
NTDs including trachoma, schistosomiasis, lymphatic
filariasis and onchocerciasis [29, 30]. Similarly, in
1994, a UK working party developed simplified diag-
nostic criteria for atopic dermatitis to be used in epi-
demiological studies [31–34]. The simplified criteria
for scabies comprise a brief examination of frequently
exposed skin, which may facilitate implementation at
large scale with limited resources by using less specia-
lised local healthcare workers and reducing the num-
ber of interpreters required. Studies comparing the
accuracy of examination of exposed areas of the skin
to examination of the whole body found that examin-
ation of exposed areas had close to 90% sensitivity
[14, 35]. Omitting contact history and consideration
of atypical lesions should further simplify training and
assessment in the field. In addition, it may increase
recruitment rates by omitting examination of sensitive
body areas and reducing the time burden placed on
participants. Our exploration of alternatives to the
simplified criteria showed that it is possible to im-
prove sensitivity by including cases with atypical le-
sions. However, three of the four of these alternative
methods (ASC1, ASC2, ASC3) overestimated the
prevalence of scabies. Therefore, our data support the
current recommendations for the simplified criteria.
Prevalence estimates using ASC4 (presence of itch
and contact history) were similar to those using 2020
IACS criteria. However, itch is a highly non-specific
symptom which is caused by many common condi-
tions, and is variably reported, including in young
children. Further studies would be required to investi-
gate whether an assessment method that omits exam-
ination of the skin could be a feasible alternative to
the proposed simplified criteria.
The simple, brief nature of scabies assessment may facili-
tate integration with surveys for other NTDs and other
health programmes [36, 37]. Epidemiological mapping of on-
chocerciasis (REMO) integrates geographical and environ-
mental risk factors with mapping data to establish zones of
endemicity [38]. Although no such risk factors have been
established for scabies, and scabies is not a vector-borne dis-
ease, this could be explored through future research.
Table 6 Diagnostic accuracy of simplified diagnostic compared to 2020 IACS criteria
TP TN FP FN Sn % (95% CI) Sp % (95% CI)
Country
Solomon Islands (n = 5224) 643 4293 145 143 81.8 (78.9, 84.4) 96.7 (96.2, 97.2)
Fiji (n = 3351) 419 2850 31 51 89.1 (86.0, 91.8) 98.9 (98.5, 99.3)
Timor-Leste (n = 951) 236 614 16 85 73.5 (68.3, 78.3) 97.5 (95.9, 98.5)
Sex
Male (n = 4537) 672 3633 100 132 83.6 (80.8, 86.1) 97.3 (96.7, 97.8)
Female (n = 4989) 626 4124 92 147 81.0 (78.0, 83.7) 97.8 (97.3, 98.2)
Age (years)
0–1 (n = 438) 115 294 20 9 92.7 (86.7, 96.6) 93.6 (90.3, 96.1)
2–4 (n = 818) 186 572 34 26 87.7 (82.5, 91.8) 94.4 (92.2, 96.1)
5–9 (n = 1741) 381 1232 59 69 84.7 (81.0, 87.9) 95.4 (94.1, 96.5)
10–14 (n = 1596) 271 1212 48 65 80.7 (76.0, 84.7) 96.2 (95.0, 97.2)
15–29 (n = 1717) 141 1515 22 39 78.3 (71.6, 84.1) 98.6 (97.8, 99.1)
30–49 (n = 1860) 118 1697 5 40 74.7 (67.2, 81.3) 99.7 (99.3, 99.9)
≥ 50 (n = 1356) 86 1235 4 31 73.5 (64.5, 81.2) 99.7 (99.2, 99.9)
Total (n = 9526) 1298 7757 192 279 82.3 (80.2, 84.2) 97.6 (97.2, 97.9)
TP = true positive, TN = true negative, FP = false positive, FN = false negative, Sn = sensitivity, Sp = specificity, CI = confidence interval
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Our study has limitations. First, the three surveys we
included are from tropical, island countries with a very
high scabies prevalence. Our results may not be general-
isable to other settings such as temperate climates,
mainland populations, highly urbanised environments or
to lower-prevalence settings. Second, the Timor-Leste
survey only enrolled school-aged children and their sib-
lings. Scabies is more prevalent in children, which may
have contributed to the difference in results between
surveys. There is also a high prevalence of secondary
impetiginized scabies in this population [19, 39, 40].
These cases may have lesions of atypical appearance or
distribution, which are not classified as scabies using the
simplified criteria. Similarly, scabies can present in more
atypical forms in the elderly population, which may have
contributed to the lower sensitivity seen in those aged
50 years and older [41]. Third, the current recommended
threshold to cease MDA is a prevalence of < 2% [16],
and further evidence is needed to compare the accuracy
of simplified criteria in lower-prevalence settings.
Fourth, we were only able to compare simplified criteria
with the ‘Clinical and Suspected Scabies’ levels of the
2020 IACS criteria, as the ‘Confirmed Scabies’ level,
which requires direct mite visualisation was not feasible
to include in these surveys. The absence of an appropri-
ate reference standard is a limitation for all studies of
diagnostic accuracy for scabies, and further development
of objective diagnostic tests that can be feasibly used in
the field is required. Fifth, we compared the accuracy of
the criteria based on an analysis of the components col-
lected during a single assessment in the field, in which
health workers were trained to assess participants ac-
cording to 2020 IACS clinical criteria. It is possible that
knowledge of contact history may have influenced the
classification of skin lesions in some cases, and it is not
known how a different training program and survey
method, based on the simplified criteria, would affect
the recording of scabies lesions. Finally, examination was
conducted by healthcare workers with limited experi-
ence, and the sensitivity of scabies diagnosis may be
lower, particularly for mild forms of scabies [15].
Conclusions
There was no significant difference between the preva-
lence of scabies using simplified diagnostic criteria, as
recommended in the informal WHO Framework, com-
pared with the 2020 IACS criteria in the pooled survey
results from these three tropical island populations. Im-
plementation of simplified criteria may be an efficient
and accurate way to facilitate rapid mapping to deter-
mine high prevalence areas for scabies control. Further
work is needed to investigate the accuracy in urbanised
and lower-prevalence populations, and to evaluate the
implementation of simplified criteria in the field setting.
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